Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOL4239 in mild to moderate plaque psoriasis
NCT01826201Phase 2Completed
- Sponsor
- Moleculin Biotech, Inc.
- Start
- Mar 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WP1220 in plaque psoriasis, sponsored by Moleculin Biotech, Inc.. Started Mar 2013; status: completed.
02
Drugs
WP1220
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01826201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01826201.